On March 19th, I interviewed the economist Dean Baker of the Center for Economic and Policy Research.
Bio
Dean Baker co-founded CEPR in 1999. His areas of research include housing and macroeconomics, intellectual property, Social Security, Medicare and European labor markets. He is the author of several books, including Rigged: How Globalization and the Rules of the Modern Economy Were Structured to Make the Rich Richer. His blog, “Beat the Press,” provides commentary on economic reporting. He received his B.A. from Swarthmore College and his Ph.D. in Economics from the University of Michigan.
Structure
1:17 Plagiarism vs. violation of intellectual property rights (IPR)
3:14 Counterfeit vs. unauthorized copy
5:14 Enforcement of IPR
8:37 Do IPR promote competition and innovation?
12:53 The plan to increase vaccine prices
16:04 Effect on the bottom line of the pharmaceutical industry if IPR are not enforced
17:37 Is corruption impeding the pandemic response?
21:50 How to overcome lobbying by the pharmaceutical industry?
References
Munk Debate with Thomas B. Cueni, Director General of the International Pharma Trade Association
Colm Quinn. Foreign Policy. Rich vs. Poor (Again) at WTO. March 10, 2021.
Dean Baker, Achal Prabhala, Arjun Jayaved. New York Times. Want Vaccines Fast? Suspend Intellectual Property Rights. December 07, 2020.
Lee Fang. The Intercept. Drugmakers Promise Investors They’ll Soon Hike Covid Vaccine Prices. March 18 2021.
CEPR. Dealing with a Pandemic as If Human Lives Mattered. February 2, 2021.
If you like my work, I would be glad if you supported it on Patreon. Thank you!
Image
Army Spc. Angel Laureano holds a vial of the COVID-19 vaccine, Walter Reed National Military Medical Center, Bethesda, Md., Dec. 14, 2020. (DoD photo by Lisa Ferdinando)
Author: U.S. Secretary of Defense
Date: December 14, 2020
Source
License
No changes made